Trulicity and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trulicity (dulaglutide) and Fluocinonide (fluocinonide). Common drug interactions include pain among females and bone fragmentation among males.

The phase IV clinical study analyzes what interactions people have when they take Trulicity and Fluocinonide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Trulicity?

Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.



On Jul, 28, 2026

17 people who take Trulicity and Fluocinonide together, and have interactions are studied.

Trulicity and Fluocinonide drug interactions.

What are the common drug interactions of Trulicity and Fluocinonide, by gender? *:

female:

  1. Pain
  2. Erythema (redness of the skin)
  3. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  4. Discomfort
  5. Pruritus (severe itching of the skin)
  6. Rash
  7. Skin swelling
  8. Chronic kidney disease
  9. Dizziness
  10. Anaemia (lack of blood)

male:

  1. Bone fragmentation
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Fall
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Ligament rupture (tear in ligament)
  6. Localised infection (infection at the single location)
  7. Post procedural complication
  8. Procedural pain
  9. Respiratory disorder (respiratory disease)
  10. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)

What are the common drug interactions of Trulicity and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  2. Discomfort
  3. Erythema (redness of the skin)
  4. Pruritus (severe itching of the skin)
  5. Rash
  6. Skin swelling

50-59:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
  6. Fatigue (feeling of tiredness)
  7. Gait disturbance
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Lacrimation increased
  10. Pain

60+:

  1. Pain
  2. Dizziness
  3. Constipation
  4. Diarrhoea
  5. Dizziness exertional
  6. Eating disorder
  7. Erythema (redness of the skin)
  8. Exostosis (formation of new bone on the surface of a bone)
  9. Heart rate irregular
  10. Hemiparesis (weakness on one side of the body)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 3 people, 17.65%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 17.65%
  3. High Blood Pressure: 2 people, 11.76%
  4. Multiple Myeloma (cancer of the plasma cells): 2 people, 11.76%
  5. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 11.76%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
  7. Insomnia (sleeplessness): 2 people, 11.76%
  8. High Blood Cholesterol: 2 people, 11.76%
  9. Type 2 Diabetes: 1 person, 5.88%
  10. Cushing's Syndrome (obesity, a rounded face, increased fat): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Trulicity and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trulicity and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trulicity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trulicity and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dulaglutide and fluocinonide (the active ingredients of Trulicity and Fluocinonide, respectively), and Trulicity and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: